Search Results - Popat S

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Mortality Outcomes in People with Lung Cancer with and without Type2 Diabetes: A Cohort Study in England

    Mortality Outcomes in People with Lung Cancer with and without Type2 Diabetes: A Cohort Study in England by Igbinosa EG, Dharmasekara B, Quint JK, Popat S, Bhaskaran K, Morganstein D, Cook S

    Published 2025-07-01

    Eseosa Grace Igbinosa,1,2 Bodini Dharmasekara,1 Jennifer K Quint,1 Sanjay Popat,3 Krishnan Bhaskaran,4 Daniel Morganstein,3,5 Sarah Cook1 1School of Public Health, Imperial College London, London, UK; 2School of Computer Science and Mathematics, Keele University, Staffordshire, UK; 3Lung Unit, The R...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Bioactive Compound-Fortified Nanomedicine in the Modulation of Reactive Oxygen Species and Enhancement of the Wound Healing Process: A Review

    Bioactive Compound-Fortified Nanomedicine in the Modulation of Reactive Oxygen Species and Enhancement of the Wound Healing Process: A Review by Popat Mohite, Abhijeet Puri, Shubham Munde, Nitin Ade, Aarati Budar, Anil Kumar Singh, Deepanjan Datta, Supachoke Mangmool, Sudarshan Singh, Chuda Chittasupho

    Published 2025-06-01

    Wound healing is a complex biological process that involves the regulation of reactive oxygen species (ROS), which play a critical role in cellular signaling and tissue repair. While the dual nature of ROS means that maintaining controlled levels is essential for effective wound healing, excessive R...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Longitudinal Assessment of Stereotactic Radiosurgery Outcomes in Brain Arteriovenous Malformations: Continuous Monitoring of Treatment Effects

    Longitudinal Assessment of Stereotactic Radiosurgery Outcomes in Brain Arteriovenous Malformations: Continuous Monitoring of Treatment Effects by Prem Kumar Reddy Gopireddy, Ashok Bhanage, Anand Katkar, Ashok Hande, Rahul Sharma, Ajay Kaushik, Chintan Popat, Neeraj Dhingra, Sathiyanarayanan Kumaraswami Vatyam, Raghavendra Holla

    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center

    Guadecitabine improved relapse-free survival in high-risk acute myeloid leukemia and myelodysplastic syndrome patients after transplant: phase II results from a single center by Betül Oran, Peter Thall, Amin Alousi, Gheath Al-Atrash, Rohtesh Mehta, David Marin, Partow Kebriaei, Uday Popat, Roland Bassett, Qaiser Bashir, Jin Im, Amanda Olson, Jessica Jewell, Portia Smallbone, Elizabeth Shpall, Richard Champlin

    Published 2025-07-01

    This phase 2, single-center clinical trial evaluated the efficacy and safety of guadecitabine, with or without donor lymphocyte infusion, following allogeneic stem cell transplantation (allo-SCT) in adult patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). The study had t...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: